Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer

Alexandros Ardavanis, Panteleimon Kountourakis, Flora Kyriakou, Savoula Malliou, Ioannis Mantzaris, Anastasia Garoufali, Ioulia Yiotis, Andreas Scorilas, Nikolaos Baziotis, Gerasimos Rigatos

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences